Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combining Epigenetic And Immune Therapy to Beat Cancer. CAIRE Study

NCT04705818 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT04705818
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04705818 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combining Epigenetic And Immune Therapy to Beat Cancer. CAIRE Study
Lead sponsor
Institut Bergonié
Phase
Phase 2
Overall status
Completed
Start date
July 23, 2021
Completion date
July 17, 2025
Enrollment
164 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

adult solid tumor, advanced colorectal carcinoma, advanced pancreatic adenocarcinoma, advanced soft-tissue sarcoma, advanced solid tumor